Avelumab for Bladder Cancer

"Currently, there are 116 global clinical trials underway for Avelumab in over 1000 cities across 52 countries. The first trial began in 2014 and was sponsored by EMD Serono Research & Development Institute, Inc. That initial study involved 204 patients and completed Phase 2 drug approval. To date, 70 total trials have been completed since 2014."

"Port Macquarie Base Hospital was the first medical institution to study avelumab in 2014. Since then, there have been 70 completed studies with 116 more presently ongoing. Many of these active trials are being conducted out of Aurora, Colorado."

"Unfortunately, this trial is not currently open for recruitment. The listing was created on April 25th, 2016 and last updated on October 24th, 2022. However, there are other trials that may be of interest. There are 32 urothelial cancer studies and 116 Avelumab trials that are still seeking participants."

"Avelumab is classified as a 3 on our Power team's safety scale. This is due to the fact that it has reached Phase 3 in clinical trials, meaning that there is both anecdotal and empirical evidence supporting its efficacy and safety."

"There are a total of 19 locations running this clinical trial, some of which include University of Colorado Denver, CTO (CTRC) in Aurora, University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP) in New Haven, and Smilow Cancer Hospital at Yale-New Haven in Seattle."